Concepedia

Tim Wert

TW

Statistics

Publications

4

Citations

63

H-Index

4

Active since

2020

Affiliations

Taiho Oncology (United States)(Current)

Yale Cancer Center

Pharmerit (United States)

Tim Wert is an author at Taiho Oncology (United States) specializing in myelodysplastic syndromes, hypomethylating agents, and health services research.

Publications per year

2020–2022

4

Publications

4

Under-use of Hypomethylating Agents in Patients With Higher-risk Myelodysplastic Syndrome in the United States: A Large Population-based Analysis

Shelby Corman, Namita Joshi, Tim Wert et al. · Clinical Lymphoma Myeloma & Leukemia · 2020 · 25 citations · Full text

, , +15

Patient Preferences for Benefits, Risks, and Administration Route of Hypomethylating Agents in Myelodysplastic Syndromes

Amer M. Zeidan, Jui‐Hua Tsai, Milad Karimi et al. · Clinical Lymphoma Myeloma & Leukemia · 2022 · 15 citations · Full text

, , +17

Direct Medical Costs Associated With Treatment Nonpersistence in Patients With Higher-Risk Myelodysplastic Syndromes Receiving Hypomethylating Agents: A Large Retrospective Cohort Analysis

Namita Joshi, Hrishikesh Kale, Shelby Corman et al. · Clinical Lymphoma Myeloma & Leukemia · 2020 · 12 citations · Full text

, , +16

Persistence to hypomethylating agents and clinical and economic outcomes among patients with myelodysplastic syndromes

Wendy Y. Cheng, Ambika Satija, Hoi Ching Cheung et al. · Hematology · 2021 · 11 citations · Full text

, , +16

1–4 of 4